The synthesis of selected phase II metabolites - O-glucuronides and sulfates of drug development candidates

Arkivoc

Volumn 2012, Issue 3, 2012, Pages 257-278

  Atzrodt, Jens ^a   Derdau, Volker ^a   Holla, Wolfgang ^a   Sandvoss, Martin ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Acyl glucuronides; Glucuronides; Metabolite analysis; Phase II metabolites; Sulfates

Indexed keywords

EID: 84879332148     PISSN: 1551-7012     EISSN: 15517004     Source Type: Journal    
DOI: 10.3998/ark.5550190.0013.319     Document Type: Article

References (79)

1. King, R. S. In Drug Metabolism Handbook: Concepts and Applications; Nassar, A. F.; Hollenberg, P. F.; Scatina, J. Eds., John: Hoboken, 2009, pp 3-38.
2. Dudda, A.; Kürzel, G.-U. In Drug Discovery and Evaluation Safety and Pharmacokinetic Assays; Vogel, H.; Hock F.; Maas, J.; Mayer, D. Eds.; Springer: Berlin, Heidelberg, New York, 2006, pp 151-193.
3. Baillie, T. A.; Cayen, M. N.; Fouda, H.; Gerson, R. J.; Green, J. D.; Grossman, S. J.; Klunk, L. J.; LeBlanc, B.; Perkins, D. G.; Shipley, L. A.; Toxicol. Appl. Pharmacol. 2002, 182, 188.
4. Shipkova, M.; Armstrong, V. W.; Oellerich, M.; Wieland, E. Ther. Drug. Monit. 2003, 25, 1.
5. US Department of Health and Human Services, Food and Drug Administration Guidance for Industry, Safety Testing of Drug Metabolites, 2008.
6. (a) Nedderman, A. N. R. Biopharm. Drug Dispos. 2009, 30, 153-162.
7. (b) Humphreys, W. G.; Unger, S. E. Chem. Res. Toxicol. 2006, 19, 1564.
8. (c) Prakash, C.; Shaffer, C.L.; Nedderman A. Mass. Spectrom. Rev. 2007, 26, 340.
9. Robison, T. W.; Jacobs; Future Science Bioanalysis, 2009, 1, 1193.
10. (b) Nedderman, A. N. R.; Wright, P. Bioanalysis 2010, 2, 1235.
11. (b) Baillie, T. A.; Chem. Res. Toxicol. 2009, 22, 263.
12. (c) Smith, D. A.; Obach, R. S. Chem. Res. Toxicol. 2006, 19, 1570.
13. Davis-Bruno, K. L.; Atrakchi, A. Chem. Res. Toxicol. 2006, 19, 1561.
14. (b) Smith, D. A.; Obach, R. S. Drug. Metab. Dispos. 2005, 33, 1409.
15. Walker, D.; Brady, J.; Dalvie, D.; Davis, J.; Dowty, M.; Duncan, J. N.; Nedderman, A.; Obach, R. S.; Wright P. Chem. Res. Toxicol. 2009, 22, 1653.
16. H. Atrakchi, A. K. Chem. Res. Toxicol. 2009, 22, 12170.
17. Luffer-Atlas, D. Drug. Metab. Rev. 2008, 40, 447.
18. Drǎgon, C.-A.; Buchheit, D.; Bischoff, D.; Ebener, T.; Bureik, M. Drug Metab. Dispos. 2010, 38, 509.
19. Zöllner, A.; Buchheit, D.; Mayer, M. R.; Maurer, H. H.; Peters, F. T.; Bureik, M. Bioanalysis 2010, 2, 1277.
20. For review of glucuronidation methods and the preparation of the most common glucuronate glycosyl donors see Stachulski, A. V.; G. Jenkins, G. Natural Product Reports 1998, 173.
21. Regan, S. I.; Maggs, J. I.; Hammond, T. G.; Lambert, C.; Williams, D. P.; Park, B. K. Biopharm. Drug. Dispos. 2010, 31, 367.
22. Vanderhoeven, S. J.; Lindon, J. C.; Troke, J.; Tranter, G. E.; Wilson, I. D.; Nicholson, J. K. Xenobiotica, 2004, 34, 73.
23. (a) Mulder, G. J. Annu. Rev. Pharmacol. Toxicol. 1992, 32, 25.
24. (b) Faed, M. E. Drug. Metab. Rev. 1984, 15, 1213.
25. (c) Verbeeck, R. K. Drug Metab. Dispos. 1982, 10, 87.
26. Stachulski, A. V.; Jenkins, G. N. Nat. Prod. Rep. 1997, 15, 173.
27. (a) Becker, R.; Barua, A. B.; Olson, J. A. Biochem. J. 1996, 25, 212.
28. (b) Barua, A. B.; Olson, J. A. J. Lipid. Res. 1985, 26, 1277.
29. Panfil, I.; Lehman, P. A.; Zimniak, P.; Ernst, B.; Franz, T.; Lester, R.; Radominska, A. Biochim. Biophys. Act. 1992, 1126, 221.
30. (b) Smith III, A. B.; Hale, K. J.; Rivero, R. A. Tetrahedron Lett. 1986, 27, 5813.
31. Schmidt, R. R.; Grundler, G. Synthesis, 1981, 885.
32. (b) Schmidt, R. R.; Ruecker, E. Tetrahedron Lett. 1980. 21, 1421.
33. De Mesmaker, A.; Hoffmann, P.; Ernst, B. Tetrahedron Lett. 1989, 30, 3773.
34. (b) Bugianesi, R.; Shen, T. Y. Carbohydrate Res. 1971, 19, 179.
35. (a) Juteau, H.; Gareau, Y.; Labelle, M. Tetrahedron Lett. 1997, 38, 1481.
36. (b) Kenny, J. R.; Maggs, J. L.; Meng, X.; Sinnott, D.; Clarke, S. E.; Park, B. K.; Stachulski, A. V. J. Med. Chem. 2004, 47, 2816.
37. Perrie, J. A.; Harding, J. R.; Holt, D. W.; Johnston, A.; Meath, P.; Stachulski, A. V. Org. Lett. 2005, 7, 2591.
38. Smith III, A. B.; Rivero, R. A.; Hale, K. J.; Vaccaro, H. A. J. Am. Chem. Soc. 1991, 113, 2092.
39. (a) Akin, A.; Curran T. T. Synth. Comm. 2005, 35, 1649.
40. (b) Biesalski, H.-K.; Doepner, G.; Kunz, H.; Paust, J.; Liebigs. Ann. 1995, 717.
41. Baba, A.; Yoshioka, T. Org. Biomol. Chem. 2006, 4, 3303;
42. see also (b) Kunz, H.; Kullmann, R.; Werning, P.; Zimmer, J. Tetrahedron Lett. 1992, 33, 1969.
43. Boisnard S., Sanofi, Chilly-Mazarin, personal note.
44. (a) Faed, E. M.; Drug. Metab. Rev. 1984, 15, 1213.
45. (b) Rachmel, A.; Hazelton, G. A.; Yergey, A. L.; Liberato, D. I. Drug. Metab. Dispos. 1985, 13, 705.
46. Vogt, P. F.; Hansel, J.-G.; Miller, M. J. Tetrahedron Lett. 1991, 38, 2803.
47. (a) Malkinson, J. P.; Falconer, R. A.; Toth, I. J. Org. Chem. 2000, 65, 5249.
48. (b) Fiandor, J.; Garcias-Lopez, M. T.; De Las Heras, F. G.; Mendez-Gastrillon, P. P. Synthesis, 1985, 1121.
49. Zemplén, G.; Pacsu, E. Ber. Dtsch. Chem. Ges. 1929, 62, 1613.
50. (b) Agostan K.; Dobo, A.; Rako, J.; Keregyarto, J.; Szurmai, Z. Carbohydrate Res. 2001, 330, 183.
51. Seebach, D.; Hungerbühler, E.; Naef, R.; Schnurrenberger, P.; Weidmann, B.; Zuger, M.; Synthesis, 1982, 138.
52. Vlaho, J.; Snatzke, G. Liebigs Ann. Chem. 1983, 570.
53. Suzuki, T.; Mabuchi, K.; Fukazawa, N. Bioorg. Med Chem. Lett. 1999, 9, 659.
54. (a) Ciriminna, R.; Pagliaro M. Org. Process Res. Dev., 2010, 14, 245.
55. (b) Fatiadi A. Synthesis 1987, 85.
56. (c) Tojo G.; Fernández M., Oxidation of Alcohols to Aldehydes and Ketones, Springer Berlin, 2006, 1-97.
57. (d) Trost B. M.; Fleming I.; Ley S. V. Ed., Comprehensive Organic Chemistry, Vol. 7 Oxidation, Pergamon Press: Oxford.
58. Derdau, V.; Bierer, L.; Kossenjans, M. WO 2006 072334; USPTO 2008 0207882.
59. (a) Derdau, V.; Fey, T.; Atzrodt J. Tetrahedron 2010, 66, 1472.
60. (b) Derdau, V.; Fey, T.; Atzrodt J. J. Label. Compd. Radiopharm. 2010, 53, 381.
61. Iyer, S. S,; Rele, S. M.; Baskaran, S.; Chaikof, E. L. Tetrahedron 2003, 59, 631.
62. Deng, S.; Yu, B.; Xie, J.; Hui, Y. J. Org. Chem. 1999, 64, 7265.
63. Methyl 1-bromo-1-deoxy-2,3,4-tri-O-acetyl- α-D-glucopyranuronate 2b was purchased from Fluka, the corresponding benzoyl and pivaloyl derivatives were prepared in three steps from D-glucuronolactone according to Ref. 34.
64. Bollenback, G. N.; Long, J. W.; Benjamin, D. G.; Lindquist, J. A. J. Am. Chem. Soc. 1955, 77, 3310.
65. (a) Falany, C.S. In Methods in Pharmacology and Toxicology, Drug Metabolism and Transport: Molecular Methods and Mechanisms, 2005, Ed. L. Lash, Human Press: Totowa, New Jersey, 342-375.
66. (b) Barron, D. Recent advances in polyphenol research 2008, 317-358.
67. Barron, D.; Ibrahim, R.K. Zeitschrift fuer Naturforschung C: Journal of Biosciences 1988, 43, 625.
68. (b) Shinkawa, T.; Nakajima, H.; Nishijima, K.; Yamasaki, F.; Kato, K.; Ohzawa, N.; Mizota, M. Eur. J. Pharm. 1992, 219, 217.
69. (c) Burmeister, H. R.; Vesonder, R. F. Appl. Environ. Microbiol. 1990, 56, 3209.
70. Varadi, A.; Gergely, A.; Beni, S.; Jankovics, P.; Noszal, B.; Hosztafi, S. Eur. J. Pharm. Sci. 2011, 42, 65.
71. Ishizaki, M.; Yamada, M.; Watanabe, S.; Hoshino, O.; Nishitani, K.; Hayashida, M.; Tanaka, A.; Hara, H. Tetrahedron 2004, 60, 7973.
72. Beugelmans, R.; Bourdet, S.; Bigot, A.; Zhu, J. Tetrahedron Lett. 1994, 35, 4349.
73. Bernotas, R.; Brown, P.; Emmons, G.; King, C.-H. WO0105764, US6465490.
74. (a) Offord, S. J.; Wong, D. F.; Nyberg, S. J. Clin. Pharm. 1999, 17.
75. (b) Marek, G. J.; Martin-Ruiz, R. A. A.; Artigas, F. Neuropsychopharmacology 2005, 30, 2205.
76. (c) Teegarden, B.R.; Al Shamma, H.; Xiong, Y. Curr. Top. Med. Chem. 2008, 8, 969.
77. Alpert, A. J., J. Chromatogr. A 1990, 499, 177.
78. Gilar, M.; Olivova, P.; Daly, A. E.; Gebler, J. C. Anal. Chem. 2005, 77, 6426.
79. McCalley, D. V. J. Chromatogr. A 2007, 1171, 46.